Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes

NCT05772611 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT05772611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05772611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2022
Completion date
February 15, 2029
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune encephalitis, paraneoplastic neurological syndrome